Leukemia News

Gerontology researchers and hematologic oncology investigators from Brigham and Women’s Hospital and Dana-Farber Cancer Institute have devised a scale for assessing high-risk medications in older patients with blood cancers.

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

September is Childhood Cancer Awareness Month.

As patients with cancer look to the internet for deals on costly medications, results of a study showed most online pharmacies that claimed to sell the oral chemotherapy drug imatinib engaged in illegal, unsafe or misleading activities.

Before the opening of City of Hope’s new comprehensive cancer center, many residents of Orange County, California, faced a long commute for advanced cancer care.

Several hematologists will be honored during this year’s ASH Annual Meeting, scheduled for Dec. 10-13 in New Orleans.

Certain patient demographics, including race and ethnicity and underlying primary malignant neoplasm, appeared associated with delays in cancer treatment among patients with COVID-19.

Rates for CV admissions among patients with cancer has increased, according to a study published in the European Heart Journal Quality of Care & Clinical Outcomes.Primary CV admissions are highest among patients with hematological cancer with the most common cause of admission being heart failure, according to the study.

A patient aged 72 years with high-risk myelodysplastic syndrome presents at a community hematology/oncology clinic.

A third dose of the mRNA-1273 vaccine for COVID-19 significantly improved SARS-CoV-2 antibody concentrations among patients with hematologic malignancies who previously received two doses, results of a prospective study showed.